01 June 2024
Walbrook PR, which provides high quality Financial PR, Corporate Communications and Investor Relations to Small Cap and AIM listed companies, announces it is acting as strategic communications advisor for eXymes, a high growth genomics company, with a disruptive DNA/RNA extraction technology.